ES2095236T3 - Un metodo para la produccion de glucagon. - Google Patents

Un metodo para la produccion de glucagon.

Info

Publication number
ES2095236T3
ES2095236T3 ES90300937T ES90300937T ES2095236T3 ES 2095236 T3 ES2095236 T3 ES 2095236T3 ES 90300937 T ES90300937 T ES 90300937T ES 90300937 T ES90300937 T ES 90300937T ES 2095236 T3 ES2095236 T3 ES 2095236T3
Authority
ES
Spain
Prior art keywords
glucagon
fusion protein
glu
glutamic acid
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90300937T
Other languages
English (en)
Inventor
Jun Ishizaki
Mikio Tamaki
Masaru Shin
Hiroshi Teraoka
Nobuo Yoshida
Hiroshige Tsuzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Application granted granted Critical
Publication of ES2095236T3 publication Critical patent/ES2095236T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Endocrinology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Separation By Low-Temperature Treatments (AREA)
  • Diaphragms And Bellows (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Earth Drilling (AREA)
  • Control Of El Displays (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

EL INVENTO CONSISTE EN UN NUEVO METODO PARA PRODUCIR GLUCAGON. EL METODO COMPRENDE LOS PASOS DE PREPARAR UNA PROTEINA DE FUSION MOSTRADA EN LA SIGUIENTE FORMULA: X - GLU - GLUCAGON (I) EN DONDE X ES UNA SECUENCIA LIDER DE 70-170 AMINOACIDOS, GLU ES UN RESIDUO DE ACIDO GLUTAMICO, Y GLUCAGON REPRESENTA LA SECUENCIA DE AMINOACIDOS DEL GLUCAGON, Y TRATAR LA PROTEINA DE FUSION CON UNA ENZIMA QUE HIDROLIZA ESPECIFICAMENTE LOS ENLACES PEPTIDOS Y EL EXTREMO CARBOXILO DE LOS RESIDUOS DE ACIDO GLUTARMICO, DANDO LUGAR A LA DIVISION DE LA PROTEINA DE FUSION.
ES90300937T 1989-02-01 1990-01-30 Un metodo para la produccion de glucagon. Expired - Lifetime ES2095236T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2415889 1989-02-01

Publications (1)

Publication Number Publication Date
ES2095236T3 true ES2095236T3 (es) 1997-02-16

Family

ID=12130531

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90300937T Expired - Lifetime ES2095236T3 (es) 1989-02-01 1990-01-30 Un metodo para la produccion de glucagon.

Country Status (18)

Country Link
EP (1) EP0381433B1 (es)
JP (1) JPH0748999B2 (es)
KR (1) KR0161656B1 (es)
CN (1) CN1063795C (es)
AT (1) ATE144551T1 (es)
BR (1) BR9000445A (es)
CA (1) CA2008824C (es)
DE (1) DE69028935T2 (es)
DK (1) DK0381433T3 (es)
ES (1) ES2095236T3 (es)
FI (1) FI900497A0 (es)
GR (1) GR3021965T3 (es)
HU (1) HUT54410A (es)
IL (1) IL93173A0 (es)
NO (1) NO900410L (es)
NZ (1) NZ232255A (es)
PT (1) PT93031A (es)
ZA (1) ZA90533B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506595B2 (en) * 1998-03-31 2003-01-14 Itoham Foods Inc. DNAs encoding new fusion proteins and processes for preparing useful polypeptides through expression of the DNAs
CN100480374C (zh) * 2001-09-28 2009-04-22 中国科学院上海生命科学研究院 制备重组人类胰高血糖素肽－1氨基酸7－37肽段的方法
JP6054861B2 (ja) * 2010-03-26 2016-12-27 ノヴォ ノルディスク アー／エス 新規のグルカゴン類似体
TWI596110B (zh) 2011-09-23 2017-08-21 諾佛 儂迪克股份有限公司 新穎升糖素類似物
AU2014255608B2 (en) 2013-04-18 2018-01-25 Novo Nordisk A/S Stable, protracted GLP-1/glucagon receptor co-agonists for medical use
CN106536547A (zh) 2014-06-04 2017-03-22 诺和诺德股份有限公司 用于医疗用途的glp‑1/胰高血糖素受体共激动剂
CN104593399A (zh) * 2014-12-22 2015-05-06 广西大学 一种转基因胰岛素的合成工艺

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK27885A (da) * 1985-01-22 1986-07-23 Novo Industri As Fremstilling af peptider
US4743679A (en) * 1986-02-24 1988-05-10 Creative Biomolecules, Inc. Process for producing human epidermal growth factor and analogs thereof

Also Published As

Publication number Publication date
CA2008824A1 (en) 1990-08-01
GR3021965T3 (en) 1997-03-31
JPH03254692A (ja) 1991-11-13
CN1046559A (zh) 1990-10-31
DK0381433T3 (da) 1996-11-18
KR900013077A (ko) 1990-09-03
ATE144551T1 (de) 1996-11-15
ZA90533B (en) 1990-10-31
EP0381433B1 (en) 1996-10-23
JPH0748999B2 (ja) 1995-05-31
KR0161656B1 (ko) 1998-11-16
HU900614D0 (en) 1990-04-28
NZ232255A (en) 1992-03-26
AU634999B2 (en) 1993-03-11
NO900410L (no) 1990-08-02
CA2008824C (en) 1997-08-05
DE69028935T2 (de) 1997-03-06
HUT54410A (en) 1991-02-28
NO900410D0 (no) 1990-01-29
AU4898990A (en) 1990-08-09
CN1063795C (zh) 2001-03-28
BR9000445A (pt) 1991-01-15
EP0381433A1 (en) 1990-08-08
DE69028935D1 (de) 1996-11-28
PT93031A (pt) 1990-08-31
FI900497A0 (fi) 1990-01-31
IL93173A0 (en) 1990-11-05

Similar Documents

Publication Publication Date Title
EP0591524A4 (es)
AU7149691A (en) Process for enzymatical cleavage of recombinant proteins by means of iga proteases
HUT54213A (en) Process for the enzymatic removal of n-terminal sequence of proteins
ATE81673T1 (de) Verfahren zur beseitigung von nendaminos|ureresten aus eukaryotpolypeptidanlagen und so erzeugte polypeptide.
NZ232742A (en) Yeast heterologous protein production method, vectors, dna constructs and proteins so produced and aprotinin (1-58) so produced
PT92603A (pt) Processo de producao de factor de crescimento transformante, quimerico,beta
ES2095236T3 (es) Un metodo para la produccion de glucagon.
DK0642307T3 (da) Fremgangsmåde til fremstilling af et valleproteinhydrolysat og et valleproteinhydrolysat
AU553832B2 (en) Insolin from proinsulin
MX21559A (es) Un procedimiento para la produccion de proteinas hidrolizadores y productos de los mismos.
CA2025350A1 (en) Process for production of c-terminal .alpha.-amidated peptide
DE60040771D1 (de) Verfahren zur kontrolle der spaltung mit ompt protease
UY23352A1 (es) Proceso para la produccion de proteinas hidrolizadas.-
HU912398D0 (en) An in-vitro process for fusion of proteins
DE3887854D1 (de) Verfahren zur Herstellung von Dipeptiden.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 381433

Country of ref document: ES